Presented by Prof. Camilla Tincati, the study “Severe Acute COVID-19 Is Associated With Depressive Symptoms and Reduced Anxiety Resolution During Post-Acute Follow-Up” explores the relationship between the severity of acute COVID-19 and mental health outcomes during post-acute follow-up.

This work reflects the continued collaboration of EuCARE researchers and partners to better understand the long-term impact of COVID-19 and contribute to the growing evidence on Long COVID.

Congratulations to Camilla Tincati and all the co-authors involved!

The post Another EuCARE study is heading to an international stage! appeared first on EuCARE.

The post What does EuCARE really mean? appeared first on EuCARE.

Over two days, researchers, healthcare professionals, policymakers and project partners will come together to reflect on the knowledge generated throughout the EuCARE project and discuss how it can help strengthen pandemic preparedness for the future.

Join us as we share key findings, foster collaboration and explore the legacy of EuCARE in advancing evidence-based public health.

More information, including the full programme and registration details, will be available soon.

Rome, Italy
1–2 October 2026

The post The EuCARE Final Conference is coming soon appeared first on EuCARE.

At EuCARE, we remain committed to advancing research, fostering collaboration and strengthening pandemic preparedness – while embracing the slower pace of the season.

Thank you for following our journey. We wish you a restful summer and look forward to sharing more updates with you after the summer.

The post EuCARE wishes a happy summer break appeared first on EuCARE.

This Ebola Bundibugyo outbreak is teaching us again that, no matter how prepared we think we are, a new zoonotic jump, can makes us need to start everything all over again. As Ebola virus (O zairense) is the most common cause of Ebola virus disease, most diagnostic tests were developed based on this species and thus the most widely available PCR diagnostic platforms are not able to detect the Bundibugyo virus.

Also, the Bundibugyo virus presents with very unspecific symptoms and different from previous Ebola virus disease cases. For example, bleeding, a very specific symptom of Ebola virus disease, is many times missing in Ebola virus disease caused by Bundibugyo virus, making clinical suspiction more difficult.

While SARS-CoV-2 and Ebola differ significantly in their patterns of transmission, clinical presentation and public health impact, both highlight the importance of developing a solid base of evidence for preparedness, early surveillance, accurate diagnosis and timely public health action.

Recent observations from the current Ebola outbreak also remind us that diseases may not always present as expected. When symptoms are less easily recognised, detecting and containing outbreaks becomes even more challenging.

At EuCARE, we believe that comparing emerging infectious diseases helps strengthen preparedness, improve surveillance and support evidence-based public health responses.

Because every lesson learned today helps us prepare for tomorrow.

The post Every outbreak is different, but every outbreak teaches us something appeared first on EuCARE.

As part of the WHO Healthcare Workers project, EuCARE is contributing to an international study exploring both the burden of Long COVID among healthcare workers and their knowledge, attitudes and practices towards the condition.

By identifying knowledge gaps and better understanding healthcare workers’ experiences, this initiative aims to support clinical training, inform healthcare policies and ultimately improve care for people living with Long COVID.

Because improving patient care starts with understanding those who provide it.

You can see more information about the study in the link, which is included in the activities of our website!

The post SCOPE STUDY appeared first on EuCARE.

Giulia Doi presented a meta-analysis on the prevalence of anxiety, depression and distress among cancer patients during the COVID-19 pandemic. The study was selected for the conference’s Plenary Session under the Enhancing Evidence for Public Health Emergencies theme.

Simone Schena presented findings from the EuCARE School Study, exploring weekday patterns of SARS-CoV-2 positivity and cycle threshold values through a large school-based screening programme in Germany.

We are proud to see EuCARE research recognised on the international stage, contributing to evidence-based medicine and strengthening the scientific knowledge that supports future public health preparedness.

You can see more information at the link!

The post EuCARE research was featured at EBMLive 2026 in Oxford appeared first on EuCARE.

As an EMHH 2026 Endorser, EuCARE was proud to support a meeting that continues to bring together researchers, clinicians and healthcare professionals to discuss the latest developments in infectious diseases and antiviral research.

The event also provided an opportunity for EuCARE partners to meet, exchange updates and discuss the next steps of the project.

Exciting developments are on the horizon, and we look forward to sharing more in the coming months.

Stay tuned.

The post As a Endorser, EuCARE was proud to support the European Meeting on HIV & Hepatitis 2026 appeared first on EuCARE.

While SARS-CoV-2 led to a global pandemic due to its highly efficient human-to-human transmission, Ebola outbreaks are typically more localized.

Understanding the rationale for these differences is essential for effective outbreak preparedness, surveillance and response.

This post marks the beginning of a new EuCARE series exploring key aspects of SARS-CoV-2 and Ebola virus, including transmission, outbreak dynamics, public health measures and lessons for future pandemic preparedness.

Stay tuned for the next post in the series.

The post Understanding the rationale for these differences is essential appeared first on EuCARE.

Bringing together clinicians, researchers and healthcare professionals, EMHH provides a platform to discuss the latest developments in HIV and hepatitis research, antiviral therapies and clinical practice.

EuCARE will be there, contributing to the exchange of knowledge and collaboration that drive progress in infectious disease research.

Stay tuned for more updates as we approach EMHH 2026.

The post Save the date! appeared first on EuCARE.